Xuejian Wang
- Molecular Biology top 10%
- Oncology top 5%
- Organic Chemistry top 10%
- Cancer Research top 10%
- Biomaterials top 5%
- Topics
- Peptidase Inhibition and Analysis (43 papers)Neuropeptides and Animal Physiology (17 papers)Histone Deacetylase Inhibitors Research (15 papers)
- Cited by
- Cancer ResearchOncologyBiomaterials
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xuejian Wang
151 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 129
- Molecular Biology 907
- Oncology 519
- Organic Chemistry 304
- Cancer Research 295
- Biomaterials 244
Countries citing papers authored by Xuejian Wang
This map shows the geographic impact of Xuejian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejian Wang more than expected).
Fields of papers citing papers by Xuejian Wang
This network shows the impact of papers produced by Xuejian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejian Wang. The network helps show where Xuejian Wang may publish in the future.
Co-authorship network of co-authors of Xuejian Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Xuejian Wang. A scholar is included among the top collaborators of Xuejian Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuejian Wang. Xuejian Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 10 | |
| 6 | 14 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 3 | |
| 12 | 4 | |
| 13 | 7 | |
| 14 | 16 | |
| 15 | 1 | |
| 16 | 2 | |
| 17 | 26 | |
| 18 | 21 | |
| 19 | 27 | |
| 20 | 15 |
About Xuejian Wang
Xuejian Wang is a scholar working on Oncology, Cellular and Molecular Neuroscience and Microbiology, having authored 159 papers that have together received 2.2k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (43 papers), Neuropeptides and Animal Physiology (17 papers) and Histone Deacetylase Inhibitors Research (15 papers). The work is most often cited by research in Cancer Research (295 citations), Oncology (519 citations) and Biomaterials (244 citations). Xuejian Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Wenfang Xu, Hao Fang, Yingjie Zhang, Enyu Guo, Tongmin Wang, Huijun Kang, Zongning Chen, Yuping Jia, Lihong Shi and Yi Tao. Their work appears in journals such as Advanced Materials, Environmental Science & Technology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.